Skip to main content

Over 27 Years of Consecutive Dividend Payments by Helios Technologies

Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in highly engineered motion control and electronic controls technology for diverse end markets, announced that its Board of Directors declared a quarterly cash dividend of $0.09 per common share. Helios has declared consecutive quarterly dividends to its stockholders for over 27 years beginning with the first quarter 1997.

“We join an elite group of public companies as we cross this financial milestone. Since 1997, only about 10% of all companies listed on U.S. exchanges have paid consecutive dividends for 27 years in a row. This achievement highlights the enduring strong cash generation inherent in our business model combined with disciplined working capital management over the years,” said Josef Matosevic, President and Chief Executive Officer of Helios.

The dividend will be payable on April 19, 2024 to stockholders of record as of April 4, 2024. Helios Technologies has approximately 33.1 million shares of common stock outstanding.

About Helios Technologies

Helios Technologies is a global leader in highly engineered motion control and electronic controls technology for diverse end markets, including construction, material handling, agriculture, energy, recreational vehicles, marine and health and wellness. Helios sells its products to customers in over 90 countries around the world. Its strategy for growth is to be the leading provider in niche markets, with premier products and solutions through innovative product development and acquisition. The Company has paid a cash dividend to its shareholders every quarter since becoming a public company in 1997. For more information please visit: www.heliostechnologies.com and follow us on LinkedIn.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.